Specifications
Immunogen
Recombinant fusion protein containing a sequence corresponding to amino acids 25-251 of human FGF23 (NP_065689.1)
Applications
Application Notes
WB 1:2000 - 1:10000; IF/ICC 1:50 - 1:200; ELISA
Each laboratory should determine an optimum working titer for use in its particular application.
Other applications have not been tested but use in such assays should not necessarily be excluded.
Target
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody.
Learn More
Citations
Have you cited CABT-L6504Z in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Olauson, H; Larsson, TE; et al. FGF23 and Klotho in chronic kidney disease. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION 22:397-404(2013).
Zhang, X; Peyret, T; et al. POPULATION PHARMACOKINETICS OF KRN23, A HUMAN ANTI-FGF23 ANTIBODY DEVELOPED FOR THE TREATMENT OF ADULTS WITH X-LINKED HYPOPHOSPHATEMIA.. CLINICAL PHARMACOLOGY & THERAPEUTICS 97:S82-S82(2015).
COA
Certificate of Analysis
